From: Bronchoscopy in the post-acute phase of COVID-19: an observational study
Indication for bronchoscopy | Non-Hospitalized in the acute phase (n = 16) | Hospitalized in the acute phase (n = 29) | p-value | |
---|---|---|---|---|
Bronchoscopy 1 | Suspected tracheal stenosis | 1 (6.3) | 4 (13.8) | 0.44 |
Therapeutic management of tracheal stenosis | 0 (0.0) | 2 (6.9) | 0.28 | |
Follow-up of a known tracheal stenosis/tracheostomy complication (e.g., granuloma) | 0 (0.0) | 8 (27.6) | 0.02 | |
Tracheal complications (all previous together) | 1 (6.3) | 14 (48.3) | 0.007 | |
Assistance during decannulation | 0 (0.0) | 1 (6.3) | 0.17 | |
Haemoptysis | 1 (6.3) | 0 (0.0) | 0.17 | |
Persistent parenchymal infiltrates at chest imaging | 9 (56.3) | 5 (17.2) | 0.008 | |
Suspected late infection | 2 (12.5) | 6 (20.7) | 0.49 | |
Obstructive atelectasis | 1 (6.3) | 2 (6.9) | 0.94 | |
Presence of lymphadenopathies at CT scan | 1 (6.3) | 1 (3.5) | 0.66 | |
Bronchoscopy 2 | Therapeutic management of tracheal stenosis | 0/1 (0.0) | 2/10 (20.0) | |
Follow-up of a known tracheal stenosis/tracheostomy complication (e.g., granuloma) | 1/1 (100.0) | 4/10 (40.0) | ||
Persistent parenchymal infiltrates at chest imaging | 0/1 (0.0) | 2/10 (20.0) | ||
Obstructive atelectasis | 0/1 (0.0) | 1/10 (10.0) | ||
Occurrence of lymphadenopathies at CT scan | 0/1 (0.0) | 1/10 (10.0) | ||
Bronchoscopy 3 | Follow-up of a known tracheal stenosis/tracheostomy complication (e.g., granuloma) | - | 1/2 (50.0) | |
Suspected late infection | - | 1/2 (50.0) |